Zanosar
- Product NDC
- 68118-500
- 11-digit product format
- 681180500
- Labeler code
- 68118
- Product ID
- 68118-500_5c2bec09-4b38-0d96-e063-6394a90aeb0e
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Streptozocin
- Dosage form
- POWDER, FOR SOLUTION
- Route
- INTRAVENOUS
- Labeler
- ESTEVE PHARMACEUTICALS, S.A.
- Marketing category
- UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE
- Marketing start
- 2025-07-10
- Substance
- STREPTOZOCIN
- Active strength
- 1 g/10mL
- Pharmacologic classes
- Alkylating Activity [MoA], Alkylating Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Zanosar
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| STREPTOZOCIN | 1 g/10mL |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 68118-500-01 | 68118050001 | 1 VIAL, GLASS in 1 CARTON (68118-500-01) / 10 mL in 1 VIAL, GLASS | 2025-07-10 | No | No | Current |